MedTrace Logo

The Effect of Illness Management Skill Training Applied to Patients With Schizophrenia

NCT06883734 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-03-21

No results posted yet for this study

Summary

This study was aimed to examine the effectiveness (illness management and recovery, engulfment, quality of life) of a 12-week the Illness Management Skills Training applied to patients with schizophrenia. The main questions it aims to answer are:

Hypothesis (H1-1): Illness Management Skills Training applied intervention group has lower engulfment than the control group.

Hypothesis (H1-2): Illness Management Skills Training applied intervention group has higher quality of life than the control group.

Hypothesis (H1-3): Illness Management Skills Training applied intervention group has higher illness management and recovery level than the control group.

Researchers were compared the Illness Management Skills Training to a control group (no intervention) to see if the Illness Management Skills Training works on engulfment, quality of life, illness management and recovery in patients with schizophrenia.

Participants were:

\- attended the Illness Management Skills Training, one session per week for 12 weeks, 60 minutes per session, in addition to routine outpatient clinic check-ups.

Conditions

  • Schizophenia Disorder

Interventions

BEHAVIORAL

Illness Management Skills Training

In this study, in addition to routine outpatient clinic check-ups, 12 sessions of Illness Management Skills Training were applied to the intervention group of 25 patients, each in four separate groups of 6+6+6+7 patients (Group 1, Group 2, Group 3, Group 4), once a week, for 60 minutes each. The training consisted of 1) Introduction-Getting Acquainted, 2) Recovery Goals, 3) Understanding Schizophrenia-1, 4) Understanding Schizophrenia-2, 5) Stress Vulnerability Model and Coping with Stress-1, 6) Stress Vulnerability Model and Coping with Stress-2, 7) Learning About Medication, 8) Using Medication Effectively and Monitoring Treatment, 9) Coping with Persistent Symptoms, 10) Recognizing and Monitoring Warning Signs, 11) Warning Signs My Emergency Plan, and 12) Termination sessions.

Sponsors & Collaborators

  • Selçuk University

    collaborator UNKNOWN

  • Neslihan Lok

    lead OTHER

Principal Investigators

  • Neslihan Lok, Prof. Dr · Selcuk University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-15
Primary Completion
2025-01-31
Completion
2025-02-17

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06883734 on ClinicalTrials.gov